Euclidean Capital LLC
- SEC CIK
- 0001825034
- Latest filing
- Aug 14, 2026
Holdings in Q3 2025
Holdings as of Sep 30, 2025, filed Nov 14, 2025. Long positions only; changes compare share counts with Q2 2025.
- Positions
- 11
- 0 vs. Q2 2025
- Portfolio value
- $238.0M
- −$67.7M (−22.2%) vs. Q2 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| Vanguard Ftse All-World Ex-US Index Fund922042775 | ETF | 2,578,184 | $184.0M | 77.3% | +435,500+20.3% | Added | – |
| iShares MSCI India ETF46429B598 | ETF | 369,600 | $19.2M | 8.1% | −2,055,544−84.8% | Reduced | – |
| ORICOric Pharmaceuticals, Inc. | COM | 989,410 | $11.9M | 5.0% | 00.0% | Unchanged | History |
| FHTXFoghorn Therapeutics Inc. | COM | 1,573,761 | $7.70M | 3.2% | 00.0% | Unchanged | History |
| ALECAlector, Inc. | COM | 1,307,858 | $3.87M | 1.6% | 00.0% | Unchanged | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 2,627,643 | $3.68M | 1.5% | 00.0% | Unchanged | History |
| SPYSPDR S&P 500 ETF Trust | ETF | 4,104 | $2.73M | 1.1% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM NEW | 82,234 | $2.12M | 0.9% | 00.0% | Unchanged | History |
| TNYATenaya Therapeutics, Inc. | COM | 1,015,705 | $1.65M | 0.7% | 00.0% | Unchanged | History |
| SRZNSurrozen, Inc. | COM NEW | 87,696 | $1.13M | 0.5% | 00.0% | Unchanged | History |
| Surrozen, Inc.86889P117 | *W EXP 08/01/203 | 170,833 | $3.42K | <0.1% | 00.0% | Unchanged | – |